Barclays’s Walgreens Boots Alliance WBA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-23,279
Closed -$279K 5747
2025
Q3
$279K Sell
23,279
-3,143,679
-99% -$36.9M ﹤0.01% 4146
2025
Q2
$36.4M Sell
3,166,958
-1,617,615
-34% -$18M 0.01% 842
2025
Q1
$53.4M Sell
4,784,573
-560,513
-10% -$6.08M 0.02% 631
2024
Q4
$49.9M Sell
5,345,086
-931,570
-15% -$8.65M 0.01% 666
2024
Q3
$56.2M Buy
6,276,656
+3,442,913
+121% +$35.4M 0.01% 626
2024
Q2
$34.3M Sell
2,833,743
-908,076
-24% -$15.4M 0.01% 745
2024
Q1
$81.2M Buy
3,741,819
+222,950
+6% +$4.95M 0.03% 439
2023
Q4
$91.9M Buy
3,518,869
+743,033
+27% +$16.6M 0.03% 443
2023
Q3
$61.7M Buy
2,775,836
+332,378
+14% +$8.84M 0.04% 424
2023
Q2
$69.6M Buy
2,443,458
+818,468
+50% +$26.7M 0.04% 358
2023
Q1
$56.2M Sell
1,624,990
-197,815
-11% -$7.02M 0.03% 425
2022
Q4
$68.1M Buy
1,822,805
+145,585
+9% +$5.47M 0.03% 365
2022
Q3
$52.7M Buy
1,677,220
+517,519
+45% +$19.2M 0.06% 297
2022
Q2
$44M Sell
1,159,701
-747,726
-39% -$32.1M 0.03% 433
2022
Q1
$85.4M Sell
1,907,427
-155,286
-8% -$7.64M 0.07% 276
2021
Q4
$108M Buy
2,062,713
+130,907
+7% +$6.34M 0.04% 328
2021
Q3
$90.9M Buy
1,931,806
+278,178
+17% +$13.4M 0.04% 352
2021
Q2
$87M Sell
1,653,628
-352,183
-18% -$18.9M 0.04% 332
2021
Q1
$110M Sell
2,005,811
-65,994
-3% -$3.26M 0.06% 243
2020
Q4
$82.6M Buy
2,071,805
+475,287
+30% +$18.4M 0.04% 302
2020
Q3
$57.3M Buy
1,596,518
+174,832
+12% +$6.84M 0.03% 363
2020
Q2
$60.3M Sell
1,421,686
-205,340
-13% -$8.72M 0.05% 297
2020
Q1
$74.4M Sell
1,627,026
-1,161,503
-42% -$58.9M 0.06% 218
2019
Q4
$164M Buy
2,788,529
+678,896
+32% +$39.1M 0.09% 181
2019
Q3
$117M Sell
2,109,633
-1,868,236
-47% -$100M 0.07% 211
2019
Q2
$217M Buy
3,977,869
+674,104
+20% +$35.8M 0.13% 125
2019
Q1
$209M Buy
3,303,765
+560,061
+20% +$38.2M 0.14% 104
2018
Q4
$187M Buy
2,743,704
+334,178
+14% +$25.9M 0.14% 98
2018
Q3
$176M Sell
2,409,526
-333,628
-12% -$22.7M 0.12% 119
2018
Q2
$165M Sell
2,743,154
-1,946,702
-42% -$125M 0.14% 112
2018
Q1
$307M Buy
4,689,856
+1,872,655
+66% +$134M 0.23% 77
2017
Q4
$205M Buy
2,817,201
+50,259
+2% +$3.54M 0.17% 107
2017
Q3
$214M Buy
2,766,942
+613,572
+28% +$49.2M 0.22% 61
2017
Q2
$169M Sell
2,153,370
-490,818
-19% -$40.4M 0.18% 80
2017
Q1
$220M Buy
2,644,188
+1,298,224
+96% +$109M 0.24% 58
2016
Q4
$111M Buy
1,345,964
+476,321
+55% +$39.4M 0.12% 133
2016
Q3
$70.1M Buy
869,643
+260,149
+43% +$21.2M 0.08% 190
2016
Q2
$50.8M Sell
609,494
-3,880
-0.6% -$313K 0.07% 250
2016
Q1
$51.5M Sell
613,374
-18,033
-3% -$1.44M 0.08% 211
2015
Q4
$53.7M Sell
631,407
-5,668
-0.9% -$481K 0.07% 258
2015
Q3
$52.9M Sell
637,075
-455,241
-42% -$41.2M 0.06% 261
2015
Q2
$91.8M Sell
1,092,316
-1,540,128
-59% -$133M 0.1% 161
2015
Q1
$221M Buy
2,632,444
+1,051,631
+67% +$83.8M 0.26% 56
2014
Q4
$120M Buy
1,580,813
+298,564
+23% +$20M 0.12% 144
2014
Q3
$75.7M Buy
1,282,249
+22,317
+2% +$1.46M 0.07% 217
2014
Q2
$93.2M Sell
1,259,932
-121,849
-9% -$8.51M 0.1% 162
2014
Q1
$91.2M Buy
1,381,781
+305,914
+28% +$19.2M 0.1% 170
2013
Q4
$61.3M Sell
1,075,867
-632,354
-37% -$36.8M 0.06% 278
2013
Q3
$90.5M Buy
1,708,221
+640,665
+60% +$32.2M 0.11% 139
2013
Q2
$47.2M Buy
+1,067,556
New +$52M 0.06% 270

Other funds holding WBA

Barclays's WBA Position: Q4 2025 in Review

Barclays sold out of Walgreens Boots Alliance (WBA) in Q4 2025, closing a stake of 23,279 shares — an estimated $279K sold.

Barclays first reported a position in WBA in Q2 2013 and held it in 50 quarters. The position peaked at $307M in Q1 2018. 2 funds tracked by Wall St. Rank hold WBA as of Q4 2025.

  • Barclays reported no remaining Walgreens Boots Alliance position as of Q4 2025 after selling out during the quarter.
  • Barclays sold 23,279 Walgreens Boots Alliance shares in Q4 2025, an estimated $279K.
  • Barclays first reported a position in Walgreens Boots Alliance in Q2 2013 and held it in 50 quarters.
  • Barclays's Walgreens Boots Alliance position peaked at $307M in Q1 2018.
  • 2 funds tracked by Wall St. Rank held Walgreens Boots Alliance as of Q4 2025.

Based on Barclays's 13F filing for Q4 2025, filed 13 Feb 2026.